BackPURE Bioscience Overview

PURE Bioscience Receivables

Track PURE Bioscience's receivables ($240K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$242000.00
↓ 15.68% YoYΔ $-45000.00 vs prior year quarter

Peer average

Loading

PURE Bioscience Receivables History

Loading

PURE Bioscience vs. peers: Receivables Comparison

Loading

PURE Bioscience Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

PURE Bioscience (PURE) FAQ

PURE Bioscience's receivables stands at $240K as of April 2026. That compares with $290K in the prior-year period — down 15.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

PURE Bioscience reported $240K in receivables versus $290K a year earlier — a 15.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $290K in the prior-year period — down 15.7% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how PURE Bioscience's receivables evolved across reporting periods, while the comparison chart places PURE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.